IRMD Stock Ownership Activity
IRADIMED CORP 13F holders
1 value investing guru has made changes to the IRADIMED CORP (IRMD) position according to the gurus' latest SEC quarterly report(s). IRMD has been bought (as a new position) by 1 guru(s)
Which gurus or hedge funds are buying IRMD now?
According to the latest SEC filing(s) IRADIMED CORP (IRMD) has been bought by David M. Polen - Polen Capital Management (new buy).
To see more about who is investing in IRADIMED CORP (IRMD), please go to the IRMD ownership page.
2025 Q2
(1 result)
Current price: $70.38
17.71%
Reported price*: $59.79
2024 Q3
(1 result)
Current price: $70.38
60.17%
Reported price*: $43.94
2024 Q2
(1 result)
Current price: $70.38
60.17%
Reported price*: $43.94
2024 Q1
(1 result)
Current price: $70.38
59.99%
Reported price*: $43.99
2023 Q2
(1 result)
Current price: $70.38
47.42%
Reported price*: $47.74
2023 Q1
(1 result)
Current price: $70.38
78.86%
Reported price*: $39.35
2022 Q4
(1 result)
Current price: $70.38
148.78%
Reported price*: $28.29
2022 Q3
(1 result)
Current price: $70.38
134.11%
Reported price*: $30.06
2022 Q2
(1 result)
Current price: $70.38
107.39%
Reported price*: $33.94
2021 Q3
(1 result)
Current price: $70.38
109.57%
Reported price*: $33.58
10 of 10
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.